|
|
|
|
|
The Niche
|
Stem Cell & Regenerative Med Newsletter
|
|
|
|
|
|
Weekly reads: Vertex & CRISPR Therapeutics, Arnold Caplan death, MS genetics
|
|
|
|
The biotechs Vertex and CRISPR Therapeutics have an interesting relationship as biotechs. They are partners are multiple levels but also are very different as companies including in size. There's been a key development in one of their partnerships. Before we jump into that, please check out the video version of my 20 stem cell and regenerative medicine predictions for 2024 …
|
|
|
|
|
|
|
|
Put on a happy face? Perspectives on Mayo Clinic stem cells for heart disease Ph3 pub
|
|
|
|
One of the first regenerative medicine talks I ever saw was on stem cells for heart disease. I was still a trainee at the time. The professor, whom I won't name, presented data from an early phase trial reporting that direct injections of some kind of cells right into the heart improved outcomes. Stem cells for heart disease arena It …
|
|
|
|
|
|
|
|
Dishing on biobots like xenobots & anthrobots vs. organoids
|
|
|
|
If you remember xenobots, mobile clusters of frog cells, now you might be interested to learn that some of the same team brings us human cell clusters called anthrobots. Both frog and human cellular clusters are considered types of biobots or robots made of cells. To me, anthrobots seem akin to human organoids or assembloids. Is there a difference? We'll …
|
|
|
|
|
|
